- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.10. | RTI partners with Codetta Bio to boost healthcare innovation | ||
| 15.10. | Samsung Biologics launches biopharmaceutical platform S-HiCon | ||
| 14.10. | Stealth's elamipretide gains FDA advisory committee support for Barth syndrome | ||
| 11.10. | Volixibat gains FDA breakthrough therapy designation | ||
| 10.10. | insitro collaborates with Lilly on metabolic disease treatments | ||
| 09.10. | PsychoGenics secures NIH contract to identify new pain therapeutics | ||
| 08.10. | Neuvivo files NDA seeking FDA approval for ALS treatment | ||
| 07.10. | AstraZeneca to license CSPC Pharmaceutical's lipid-lowering therapy | ||
| 04.10. | FDA grants priority review for AstraZeneca's Calquence sNDA | ||
| 03.10. | FDA grants fast track status for Volastra's VLS-1488 to treat ovarian cancer | ||
| 01.10. | FDA grants approval for Fresenius-Formycon's biosimilar Otulfi | ||
| 30.09. | AbbVie seeks FDA approval for non-small cell lung cancer treatment | ||
| 27.09. | Acumen Pharmaceuticals extends collaboration with Lonza for sabirnetug | ||
| 26.09. | MITEM PHARMA acquires global rights to injectable medicine from Novartis | ||
| 25.09. | Amgen's TEPEZZA gets Japan's MHLW approval for thyroid eye disease treatment | ||
| 24.09. | FDA grants fast track designation for Elevation Oncology's EO-3021 | ||
| 23.09. | EMA CHMP recommends AbbVie's mirvetuximab soravtansine for ovarian cancer | ||
| 20.09. | Hyphens Pharma introduces new eczema hand balm | ||
| 19.09. | Azitra's ATR-04 receives FDA fast track status for treating skin rash | ||
| 18.09. | FDA grants orphan drug status to Papillon Therapeutics' PPL-001 | ||
| 17.09. | MinervaX collaborates with Wacker Biotech for GBS vaccine production | ||
| 16.09. | Novavax announces availability of Covid-19 vaccine in US pharmacies | ||
| 13.09. | China NMPA approves Keymed Biosciences' Stapokibart for atopic dermatitis | ||
| 12.09. | ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy | ||
| 11.09. | Merck KGaA introduces single-use reactor to accelerate ADC manufacturing |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
